Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT00892177
Brief Title: Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

First Submitted : May 1, 2009
First Submitted that Met QC Criteria : May 1, 2009
First Posted : May 4, 2009 (Estimate)

Results First Submitted : March 13, 2017
Results First Submitted that Met QC Criteria : May 23, 2017
Results First Posted : June 27, 2017

Last Update Submitted that Met QC Criteria : October 4, 2019
Last Update Posted : October 21, 2019